Metraipolis › archive › dc_61a37e2d42e3

Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024) — Europe PMC PMID:41055699

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41055699
DOI
10.1007/s00392-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T12:54:57.538Z
SHA-256 of the archived text
d6dd853644b13adfedfd2b6e385dd3f1477066f163e95cad88fdee9ad82df8d5
Stable URL of this page
https://metraipolis.com/documento/dc_61a37e2d42e3

How to cite

Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024) — Europe PMC PMID:41055699 — Europe PMC (en), https://europepmc.org/article/MED/41055699 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61a37e2d42e3 (Metraipolis archive dc_61a37e2d42e3, sha256 d6dd853644b13adfedfd2b6e385dd3f1477066f163e95cad88fdee9ad82df8d5)
BibTeX
@misc{dc61a37e2d42e3,
  title = {Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022-2024) — Europe PMC PMID:41055699},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41055699},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61a37e2d42e3; sha256 d6dd853644b13adfedfd2b6e385dd3f1477066f163e95cad88fdee9ad82df8d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41055699. Agents can read the archived copy with the MCP tool read_document.